EGFR and neoplasm: The recent observation that some lung NETs express EGFR and that lung NET patient-derived tumor organoids require EGF for their growth suggests the need for clinical studies to determine whether EGFR could be a predictive biomarker for the response of a subset of lung NETs to EGFR-targeted therapies (144).